Loading organizations...
Key people at China Venture Capital Fund.
SBCVC operates as a venture capital and private equity firm, deploying both USD and RMB funds into high-growth enterprises. It invests across sectors including technology, media, telecommunications (TMT), healthcare, clean energy, and advanced manufacturing. The firm identifies and finances innovative companies at various stages, fueling expansion and technological advancement.
Established in 2000, SBCVC originated from an insight into China's burgeoning economic landscape and the need for capital to support its high-tech industries. Its foundation recognized that deep local market knowledge, combined with entrepreneurial experience, could effectively cultivate promising businesses, guiding its approach to nurturing disruptive technologies.
SBCVC partners with companies demonstrating significant market potential and pioneering new technologies. Its investment philosophy empowers these portfolio companies through strategic guidance and capital. The firm is committed to fostering innovation and accelerating the growth of enterprises poised to become leaders in their fields, contributing to economic development.
Key people at China Venture Capital Fund.
China Venture Capital Fund has 4 tracked investments across 3 companies. The latest tracked deal is $200.0M Series A in ECARX in February 2021.
| Date | Company | Round | Lead Investor(s) | Co-Investor(s) |
|---|---|---|---|---|
| Feb 25, 2021 | ECARX | $200.0M Series A | China Venture Capital Fund | — |
| Dec 11, 2020 | Avant Meats | $3.1M Seed | — | Markus Haefeli, 208 Seed Ventures, Karen Contet, CPT Capital, Lever VC, Loyal VC, Particlex, PTG Food |
| May 1, 2019 | Alphamab Oncology | $60.0M Series B | Hudson BAY Capital | Cventures, Adrian Cheng, Advantech Capital, PAG |
| Nov 1, 2018 | Alphamab Oncology | $100.0M Series A | — | OrbiMed, Advantech Capital, Heritage Provider Network, Janchor Partners, PAG |